Rheumatology and therapy

Keyphrases

Publications

2023

Paul Emery, Yoshiya Tanaka, Vivian P Bykerk, Thomas W J Huizinga, Gustavo Citera, Clifton O Bingham, Subhashis Banerjee, Benjamin P Soule, Marleen Nys, Sean E Connolly, Karissa L Lozenski, Joe Zhuo, Robert Wong, Kuan-Hsiang Gary Huang, Roy Fleischmann
Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis. Rheumatology and therapy (2023)
Vivian P Bykerk, Peter Nash, David Nicholls, Yoshiya Tanaka, Kevin Winthrop, Christina Popova, Nicola Tilt, Derek Haaland
Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data. Rheumatology and therapy (2023)
Victoria Navarro-Compán, Xenofon Baraliakos, Marina N Magrey, Andrew Östör, Christopher D Saffore, Manish Mittal, In-Ho Song, Fabiana Ganz, Jayne Stigler, Atul A Deodhar
Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis. Rheumatology and therapy (2023)
Bernard G Combe, Yoshiya Tanaka, Maya H Buch, Peter Nash, Gerd R Burmester, Alan J Kivitz, Beatrix Bartok, Alena Pechonkina, Katrina Xia, Kahaku Emoto, Shungo Kano, Thijs K Hendrikx, Robert B M Landewé, Daniel Aletaha
Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study. Rheumatology and therapy (2023)
Marco Garrido-Cumbrera, Eduardo Collantes-Estévez, Victoria Navarro-Compán, Pedro Zarco-Montejo, Carlos Sastre, José Correa-Fernández, Jordi Gratacós
Patients with Axial Spondyloarthritis are Great Consumers of Healthcare Resources, Especially Young and Women: Results from the Spanish Atlas. Rheumatology and therapy (2023)
Victoria Navarro-Compán, Xenofon Baraliakos, Marina N Magrey, Andrew Östör, Christopher D Saffore, Manish Mittal, In-Ho Song, Fabiana Ganz, Jayne Stigler, Atul A Deodhar
Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis. Rheumatology and therapy (2023)
Feng-Qiao Gao, Jun-Mei Zhang, Cai-Feng Li
Clinical Presentation and Treatment of Juvenile Idiopathic Arthritis Combined with Lung Disease: A Narrative Review. Rheumatology and therapy (2023)
Bernard G Combe, Yoshiya Tanaka, Maya H Buch, Peter Nash, Gerd R Burmester, Alan J Kivitz, Beatrix Bartok, Alena Pechonkina, Katrina Xia, Kahaku Emoto, Shungo Kano, Thijs K Hendrikx, Robert B M Landewé, Daniel Aletaha
Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study. Rheumatology and therapy (2023)
Clifton O Bingham, Shawn Black, Natalie J Shiff, Stephen Xu, Wayne Langholff, Jeffrey R Curtis
Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study. Rheumatology and therapy (2023)
Chenghua Weng, Zongnan Ding, Yiqun Zhou, Qinyi Yang, Leixi Xue, Lei Zhang, Gang Wang, Zhichun Liu
Clinical Characteristics of Dermatomyositis with Interstitial Lung Disease: A Retrospective Case-Control Study. Rheumatology and therapy (2023)
Ryo Yanai, Nobuyuki Yajima, Nao Oguro, Yasuhiro Shimojima, Shigeru Ohno, Hiroshi Kajiyama, Kunihiro Ichinose, Shuzo Sato, Michio Fujiwara, Yoshia Miyawaki, Ryusuke Yoshimi, Takashi Kida, Yusuke Matsuo, Keisuke Nishimura, Ken-Ei Sada
Number of Attending Physicians and Accumulated Organ Damage in Patients with Systemic Lupus Erythematosus: LUNA Registry Cross-Sectional Study. Rheumatology and therapy (2023)
Masahiko Miyashiro, Yutaka Ishii, Celine Miyazaki, Hirohito Shimizu, Junya Masuda
A Real-World Claims Database Study Assessing Long-Term Persistence with Golimumab Treatment in Patients with Rheumatoid Arthritis in Japan. Rheumatology and therapy (2023)
Shirley P Huang, Amy Guisinger, Carlyne Averell, Christopher F Bell, Bernie Rubin
Clinical and Economic Burden of Systemic Lupus Erythematosus in the Years Preceding End-Stage Kidney Disease Diagnosis: A Retrospective Observational Study. Rheumatology and therapy (2023)
Yu Shi, Hui Jiang, Yongqiang Zhao, Jiuliang Zhao, Mengtao Li, Xiaofeng Zeng
Immune Thrombocytopenia Could be an Independent Clinical Phenotype of Antiphospholipid Syndrome: A Prospective Cohort Study. Rheumatology and therapy (2023)
Ennio Lubrano, Silvia Scriffignano, Mauro Fatica, Paola Triggianese, Paola Conigliaro, Fabio Massimo Perrotta, Maria Sole Chimenti
Psoriatic Arthritis in Males and Females: Differences and Similarities. Rheumatology and therapy (2023)
Chiara Perella, Monia Steenackers, Brian Robbins, Linda Stone, Rachel Gervais, Theresa Schmidt, Pushpendra Goswami
Patient Experience of Sjögren's Disease and its Multifaceted Impact on Patients' Lives. Rheumatology and therapy (2023)
Thomas Wj Huizinga, Ernest Choy, Amy Praestgaard, Hubert van Hoogstraten, Patrick R LaFontaine, Patricia Guyot, Daniel Aletaha, Ulf Müller-Ladner, Yoshiya Tanaka, Jeffrey R Curtis, Roy Fleischmann
Clinical Efficacy of Sarilumab Versus Upadacitinib Over 12 weeks: An Indirect Treatment Comparison. Rheumatology and therapy (2023)
Feng-Qiao Gao, Jun-Mei Zhang, Cai-Feng Li
Clinical Presentation and Treatment of Juvenile Idiopathic Arthritis Combined with Lung Disease: A Narrative Review. Rheumatology and therapy (2023)
Johannes Cornelis Nossent, Helen I Keen, David B Preen, Charles A Inderjeeth
Trends in Hospitalization for Tuberculosis and Other Opportunistic Infections in Australian Patients with Inflammatory Joint Diseases. Rheumatology and therapy (2023)
Leslie R Harrold, Keith Wittstock, Sheila Kelly, Xue Han, Ying Shan, Lin Guo, Page C Moore, Vadim Khaychuk
Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP. Rheumatology and therapy (2023)
Rieke Alten, Simon Moss, Stefanie Hahne, Angela T Muriset, David Gruben, Mark Latymer
High Usability and Applicability Ratings for the New SmartClic ® /ClicWise ® Injection Device: Evidence from a Health Care Professional Opinion Study. Rheumatology and therapy (2023)
Peter C Taylor, Yuri Sanchez Gonzalez, Ryan Clark, Freddy Faccin, Oliver Howell
Outcomes Following Adalimumab Bio-originator to Biosimilar Switch-A Comparison Using Real-world Patient- and Physician-Reported Data in European Countries. Rheumatology and therapy (2023)
Christopher F Bell, Jake Chung, Bernard Rubin
Real-World Clinical Outcomes in Belimumab-Treated US African American and Hispanic Patients with Systemic Lupus Erythematosus: A Retrospective, Observational Study. Rheumatology and therapy (2023)
Nurullah Akkoç, Carlos H Arteaga, Simone E Auteri, Marissa Betts, Kyle Fahrbach, Mindy Kim, Sandeep Kiri, Binod Neupane, Karl Gaffney, Philip J Mease
Comparative Efficacy of Biologic Disease-Modifying Anti-Rheumatic Drugs for Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Bucher Indirect Comparisons. Rheumatology and therapy (2023)

volume 10, number 2, 2023

Christopher F Bell, Jake Chung, Bernard Rubin
Real-World Clinical Outcomes in Belimumab-Treated US African American and Hispanic Patients with Systemic Lupus Erythematosus: A Retrospective, Observational Study. Rheumatology and therapy 10 (2) (2023)
Wen-Hui Xie, Hong Huang, Zhuoli Zhang
Dynamic Characteristics and Predictive Profile of Glucocorticoids Withdrawal in Rheumatoid Arthritis Patients Commencing Glucocorticoids with csDMARD: A Real-World Experience. Rheumatology and therapy 10 (2) (2023)
Wen-Hui Xie, Hong Huang, Zhuoli Zhang
Dynamic Characteristics and Predictive Profile of Glucocorticoids Withdrawal in Rheumatoid Arthritis Patients Commencing Glucocorticoids with csDMARD: A Real-World Experience. Rheumatology and therapy 10 (2) (2023)
Nurullah Akkoç, Carlos H Arteaga, Simone E Auteri, Marissa Betts, Kyle Fahrbach, Mindy Kim, Sandeep Kiri, Binod Neupane, Karl Gaffney, Philip J Mease
Comparative Efficacy of Biologic Disease-Modifying Anti-Rheumatic Drugs for Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Bucher Indirect Comparisons. Rheumatology and therapy 10 (2) (2023)
Peter C Taylor, Yuri Sanchez Gonzalez, Ryan Clark, Freddy Faccin, Oliver Howell
Outcomes Following Adalimumab Bio-originator to Biosimilar Switch-A Comparison Using Real-world Patient- and Physician-Reported Data in European Countries. Rheumatology and therapy 10 (2) (2023)
Ryo Yanai, Nobuyuki Yajima, Nao Oguro, Yasuhiro Shimojima, Shigeru Ohno, Hiroshi Kajiyama, Kunihiro Ichinose, Shuzo Sato, Michio Fujiwara, Yoshia Miyawaki, Ryusuke Yoshimi, Takashi Kida, Yusuke Matsuo, Keisuke Nishimura, Ken-Ei Sada
Number of Attending Physicians and Accumulated Organ Damage in Patients with Systemic Lupus Erythematosus: LUNA Registry Cross-Sectional Study. Rheumatology and therapy 10 (2) (2023)
Peter C Taylor, Yun-Fei Chen, Janet Pope, Michael Weinblatt, Eduardo Mysler, Andrea Rubbert-Roth, Bochao Jia, Luna Sun, Yushi Liu, Thorsten Holzkämper, Yoshiya Tanaka
Patient Disease Trajectories in Rheumatoid Arthritis Patients Treated with Baricitinib 4-mg in Four Phase 3 Clinical Studies. Rheumatology and therapy 10 (2) (2023)
Peter C Taylor, Yuri Sanchez Gonzalez, Ryan Clark, Freddy Faccin, Oliver Howell
Outcomes Following Adalimumab Bio-originator to Biosimilar Switch-A Comparison Using Real-world Patient- and Physician-Reported Data in European Countries. Rheumatology and therapy 10 (2) (2023)
Peter C Taylor, Yun-Fei Chen, Janet Pope, Michael Weinblatt, Eduardo Mysler, Andrea Rubbert-Roth, Bochao Jia, Luna Sun, Yushi Liu, Thorsten Holzkämper, Yoshiya Tanaka
Patient Disease Trajectories in Rheumatoid Arthritis Patients Treated with Baricitinib 4-mg in Four Phase 3 Clinical Studies. Rheumatology and therapy 10 (2) (2023)
Christopher F Bell, Jake Chung, Bernard Rubin
Real-World Clinical Outcomes in Belimumab-Treated US African American and Hispanic Patients with Systemic Lupus Erythematosus: A Retrospective, Observational Study. Rheumatology and therapy 10 (2) (2023)
Ryo Yanai, Nobuyuki Yajima, Nao Oguro, Yasuhiro Shimojima, Shigeru Ohno, Hiroshi Kajiyama, Kunihiro Ichinose, Shuzo Sato, Michio Fujiwara, Yoshia Miyawaki, Ryusuke Yoshimi, Takashi Kida, Yusuke Matsuo, Keisuke Nishimura, Ken-Ei Sada
Number of Attending Physicians and Accumulated Organ Damage in Patients with Systemic Lupus Erythematosus: LUNA Registry Cross-Sectional Study. Rheumatology and therapy 10 (2) (2023)
Nurullah Akkoç, Carlos H Arteaga, Simone E Auteri, Marissa Betts, Kyle Fahrbach, Mindy Kim, Sandeep Kiri, Binod Neupane, Karl Gaffney, Philip J Mease
Comparative Efficacy of Biologic Disease-Modifying Anti-Rheumatic Drugs for Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Bucher Indirect Comparisons. Rheumatology and therapy 10 (2) (2023)
Ryo Yanai, Nobuyuki Yajima, Nao Oguro, Yasuhiro Shimojima, Shigeru Ohno, Hiroshi Kajiyama, Kunihiro Ichinose, Shuzo Sato, Michio Fujiwara, Yoshia Miyawaki, Ryusuke Yoshimi, Takashi Kida, Yusuke Matsuo, Keisuke Nishimura, Ken-Ei Sada
Number of Attending Physicians and Accumulated Organ Damage in Patients with Systemic Lupus Erythematosus: LUNA Registry Cross-Sectional Study. Rheumatology and therapy 10 (2) (2023)
Peter C Taylor, Yun-Fei Chen, Janet Pope, Michael Weinblatt, Eduardo Mysler, Andrea Rubbert-Roth, Bochao Jia, Luna Sun, Yushi Liu, Thorsten Holzkämper, Yoshiya Tanaka
Patient Disease Trajectories in Rheumatoid Arthritis Patients Treated with Baricitinib 4-mg in Four Phase 3 Clinical Studies. Rheumatology and therapy 10 (2) (2023)
Peter C Taylor, Yun-Fei Chen, Janet Pope, Michael Weinblatt, Eduardo Mysler, Andrea Rubbert-Roth, Bochao Jia, Luna Sun, Yushi Liu, Thorsten Holzkämper, Yoshiya Tanaka
Patient Disease Trajectories in Rheumatoid Arthritis Patients Treated with Baricitinib 4-mg in Four Phase 3 Clinical Studies. Rheumatology and therapy 10 (2) (2023)
Rieke Alten, Simon Moss, Stefanie Hahne, Angela T Muriset, David Gruben, Mark Latymer
High Usability and Applicability Ratings for the New SmartClic ® /ClicWise ® Injection Device: Evidence from a Health Care Professional Opinion Study. Rheumatology and therapy 10 (2) (2023)
Christopher F Bell, Jake Chung, Bernard Rubin
Real-World Clinical Outcomes in Belimumab-Treated US African American and Hispanic Patients with Systemic Lupus Erythematosus: A Retrospective, Observational Study. Rheumatology and therapy 10 (2) (2023)
Ryo Yanai, Nobuyuki Yajima, Nao Oguro, Yasuhiro Shimojima, Shigeru Ohno, Hiroshi Kajiyama, Kunihiro Ichinose, Shuzo Sato, Michio Fujiwara, Yoshia Miyawaki, Ryusuke Yoshimi, Takashi Kida, Yusuke Matsuo, Keisuke Nishimura, Ken-Ei Sada
Number of Attending Physicians and Accumulated Organ Damage in Patients with Systemic Lupus Erythematosus: LUNA Registry Cross-Sectional Study. Rheumatology and therapy 10 (2) (2023)
Christopher F Bell, Jake Chung, Bernard Rubin
Real-World Clinical Outcomes in Belimumab-Treated US African American and Hispanic Patients with Systemic Lupus Erythematosus: A Retrospective, Observational Study. Rheumatology and therapy 10 (2) (2023)
Rieke Alten, Simon Moss, Stefanie Hahne, Angela T Muriset, David Gruben, Mark Latymer
High Usability and Applicability Ratings for the New SmartClic ® /ClicWise ® Injection Device: Evidence from a Health Care Professional Opinion Study. Rheumatology and therapy 10 (2) (2023)
Nurullah Akkoç, Carlos H Arteaga, Simone E Auteri, Marissa Betts, Kyle Fahrbach, Mindy Kim, Sandeep Kiri, Binod Neupane, Karl Gaffney, Philip J Mease
Comparative Efficacy of Biologic Disease-Modifying Anti-Rheumatic Drugs for Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Bucher Indirect Comparisons. Rheumatology and therapy 10 (2) (2023)
Rieke Alten, Simon Moss, Stefanie Hahne, Angela T Muriset, David Gruben, Mark Latymer
High Usability and Applicability Ratings for the New SmartClic ® /ClicWise ® Injection Device: Evidence from a Health Care Professional Opinion Study. Rheumatology and therapy 10 (2) (2023)
Wen-Hui Xie, Hong Huang, Zhuoli Zhang
Dynamic Characteristics and Predictive Profile of Glucocorticoids Withdrawal in Rheumatoid Arthritis Patients Commencing Glucocorticoids with csDMARD: A Real-World Experience. Rheumatology and therapy 10 (2) (2023)
Rieke Alten, Simon Moss, Stefanie Hahne, Angela T Muriset, David Gruben, Mark Latymer
High Usability and Applicability Ratings for the New SmartClic ® /ClicWise ® Injection Device: Evidence from a Health Care Professional Opinion Study. Rheumatology and therapy 10 (2) (2023)
Wen-Hui Xie, Hong Huang, Zhuoli Zhang
Dynamic Characteristics and Predictive Profile of Glucocorticoids Withdrawal in Rheumatoid Arthritis Patients Commencing Glucocorticoids with csDMARD: A Real-World Experience. Rheumatology and therapy 10 (2) (2023)
Nurullah Akkoç, Carlos H Arteaga, Simone E Auteri, Marissa Betts, Kyle Fahrbach, Mindy Kim, Sandeep Kiri, Binod Neupane, Karl Gaffney, Philip J Mease
Comparative Efficacy of Biologic Disease-Modifying Anti-Rheumatic Drugs for Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Bucher Indirect Comparisons. Rheumatology and therapy 10 (2) (2023)